Categories: EHRHealthcareNews

Denise Ceule Appointed as Chief Legal Officer at ModMed

BOCA RATON, Fla.–(BUSINESS WIRE)–Medical practice technology leader ModMed® is delighted to announce the appointment of Denise Ceule as its Chief Legal Officer. With an impressive track record of over 20 years in the healthcare industry, Denise brings extensive expertise in securities law, corporate governance, mergers and acquisitions, capital raising, compliance, and administration to her new role at ModMed.




Denise Ceule’s previous experience includes her tenure as Chief Legal Officer at naviHealth, a prominent provider in post-acute care management and care transitions. During her time at naviHealth, Denise led her legal, compliance, and information security teams in supporting a high-growth business and contributing to the development of groundbreaking strategic solutions.

Prior to naviHealth, Denise served as Corporate Secretary and Vice President, Law – Corporate and Securities, at Change Healthcare, formerly Emdeon. In this capacity, she played a pivotal role in supporting the company’s successful initial public offering in 2009 and its joint venture with McKesson in 2017, solidifying her reputation as a strategic legal expert.

Denise’s exceptional career also includes her time as Senior Legal Counsel at CVS Caremark, where she played a crucial role in the complex merger between Caremark Rx, Inc., and CVS Corporation in 2007.

Denise Ceule holds a bachelor of arts degree from Rhodes College and a doctor of law degree from the University of Memphis Cecil C. Humphreys School of Law. Her outstanding educational background, combined with her extensive experience, showcases her commitment to excellence and continuous professional development.

“We are thrilled to welcome Denise Ceule to our executive leadership team as our Chief Legal Officer,” said Daniel Cane, ModMed co-founder and CEO. “Denise’s deep knowledge of healthcare law, coupled with her impressive track record in strategic legal support, will be instrumental in driving our mission to revolutionize the healthcare technology landscape. We believe Denise’s expertise will play a pivotal role in our continued growth and success.”

Outside of her professional endeavors, Denise enjoys embarking on vintage treasure hunts alongside her husband. She also takes great delight in hosting kitchen dance parties with her daughter, fostering an environment of joy and creativity in her personal life.

ModMed is excited about the addition of Denise Ceule to its executive team and looks forward to leveraging her legal expertise and strategic insights to further advance the company’s mission of transforming healthcare technology.

About ModMed

ModMed is transforming healthcare by placing doctors and patients at the center of care through an intelligent, specialty-specific cloud platform. With our electronic health records (EHR) and practice management (PM) systems, and our patient engagement and revenue cycle management (RCM) services, our all-in-one solution empowers specialty medical practices by providing clinical, financial and operational software solutions. Our staff physicians help to develop products and services for allergy, dermatology, gastroenterology, OBGYN, ophthalmology, orthopedics, otolaryngology, pain management, plastic surgery, podiatry and urology practices, as well as ambulatory surgery centers. For more information, visit modmed.com. Connect with ModMed via its blog, Facebook, LinkedIn, Twitter and Instagram.

Contacts

press@modmed.com

Matter for ModMed

Dan Ventresca

617-874-5488

modmed@matternow.com

Staff

Recent Posts

Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle

Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…

1 day ago

WillowWood Rebrand by DD.NYC Wins Gold Anthem Award for Product and Innovation in 2024 Rebrand

MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…

2 days ago

Quantum Biopharma Announces Closing of Second Tranche

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…

2 days ago

Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

2 days ago

Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Bloom Burton & Co. Inc. (Bloom Burton)…

2 days ago